Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in sickle cell anemia
NCT02981329Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Mar 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of metformin in sickle cell anemia (SCA) (2 arms), sponsored by Baylor College of Medicine. Primary endpoints: Change in Fetal Hemoglobin Percentage at 1 year and Change in Total Hemoglobin at 1 year. Started Mar 2017; status: completed.
02
Drugs
metformin
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT02981329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981329.